Hansoh Pharmaceutical Group Company Ltd Financials

Market Capitalization HK$185.21 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	38.94
Forward PE	61.08
Price to Sales TTM	HK$15.11
Price to Book MRQ	HK$6.45
Enterprise to Revenue	12.50
Enterprise to EBITDA	35.82

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-12-31
Profit Margin	35.66%
Operating Margin	22.68%
Return on Assets TTM	7.54%
Return on Equity TTM	16.05%

Income Statement

Revenue TTM	HK$13,420,686,811
Revenue per Share TTM	HK$2.07
Quarterly Revenue Growth	2.90%
Gross Profit TTM	HK$12,198,350,739
EBITDA	HK$5,451,318,000
Net Income to Common TTM	HK$4,785,399,811
Diluted EPS TTM	HK$0.80
Quarterly Earnings Growth YoY	-17.20%

Balance Sheet

Total Cash MRQ	HK$25,634,705,077
Total Cash per Share MRQ	HK$3.95
Total Debt MRQ	HK$
Total Debt to Equity MRQ	0.41
Current Ratio MRQ	10.18
Book Value per Share MRQ	HK$4.83

Cash Flow

Operating Cash Flow TTM	HK$4,227,733,721
Levered Free Cash Flow TTM	HK$2,627,659,280

3692 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	5,934,335,005
Float Shares	1,119,927,702
Avg 10 Volume	10,215,685
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	81.11%
% Held by Institutions	9.50%

Stock Price Summary

Beta	0.63
Fifty Two Week Low	HK$15.32
Fifty Two Week High	HK$31.55
Fifty Two Week Change	49.21%
Day 50 MA	HK$26.20
Day 200 MA	HK$20.87

Dividends and Splits

Forward Annual Dividend Rate	HK$0.27
Forward Annual Dividend Yield	0.87%
Trailing Annual Dividend Rate	HK$0.34
Trailing Annual Dividend Yield	1.08%
Payout Ratio	42.97%
Dividend Date
Ex Dividend Date	2025-07-03
Last Split Factor
Last Split Date